Swiss company to challenge IGEN and Boehringer
This article was originally published in Clinica
Laboratoires Serono, a subsidiary of the Swiss pharmaceuticals group, Ares-Serono, has filed suit in the US, alleging that IGEN International's Origen electrochemiluminescence (ECL) technology transgresses its US patent entitled "Method of assay employing a magnetic electrode". The ECL technology is licensed to Boehringer Mannheim and used in Boehringer's Elecsys diagnostic systems.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.